Effects of sildenafil treatment on patients with Peyronie's disease and erectile dysfunction

Ozturk U., Yesil S., Goktug H. N. G., Gucuk A., Tuygun C., Sener N. C., ...Daha Fazla

IRISH JOURNAL OF MEDICAL SCIENCE, cilt.183, sa.3, ss.449-453, 2014 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 183 Sayı: 3
  • Basım Tarihi: 2014
  • Doi Numarası: 10.1007/s11845-013-1036-5
  • Dergi Adı: IRISH JOURNAL OF MEDICAL SCIENCE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.449-453
  • Anahtar Kelimeler: Peyronie's disease, Phosphodiesterase isoenzyme inhibitors, Sildenafil, Treatment, NITRIC-OXIDE SYNTHASE, MEN, INHIBITION, MANAGEMENT, ULTRASOUND, CITRATE, SYSTEM
  • Gazi Üniversitesi Adresli: Evet

Özet

It has been shown on experimental rat models that type 5-phosphodiesterase isoenzyme (PDE5) inhibitors have anti-fibrotic effects for Peyronie's disease (PD); however, this issue has not been addressed clinically. The aim of this study was to document the effects of PDE5 inhibitors used for erectile dysfunction (ED) seen in PD patients on the main course of the PD clinically.